Results 41 to 50 of about 4,496 (116)

Emerging Role of Ferroptosis in Diabetes and Associated Complications: When Metabolic Dysregulation Meets Cell Death

Cell Proliferation, Volume 59, Issue 5, May 2026.
This study identifies ferroptosis as a key driver of diabetes and its complications via iron metabolism and lipid peroxidation, elucidates organelle interactions underlying cell vulnerability, and provides insights for targeted therapies against metabolic disorders.
Zheng Wang, Ying Zhang, Yue Xu, Mengyuan Yang, Yuan Wei, Yuan Li, Tongyue Yang, Xu Wang, Chaona Yang, Qi Feng, Guolan Xing   +10 more
wiley   +1 more source

Newer agents in antiplatelet therapy: a review

Journal of Blood Medicine, 2012
Jennifer Yeung, Michael HolinstatCardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USAAbstract: Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in ...
Yeung J, Holinstat M
doaj  

Crystal structure of purinergic receptor P2Y G protein–coupled 12 (P2RY12; P2Y12) bound to an antagonist [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ATP-related purinergic signaling via P2Y12 contributes to airway epithelial barrier integrity. [PDF]

BMC Mol Cell Biol
Tsuya K, Maruoka S, Okamoto S, Shikano S, Ujike M, Yamada S, Kurosawa Y, Mizumura K, Kozu Y, Gon Y.   +9 more
europepmc   +1 more source

Inhibition of (interstitial) P2Y₆ receptors attenuates fibrosis progression. [PDF]

Pflugers Arch
Süß LM, Petzendorfer A, Tran ML, Firmke B, Süß A, Warth R, Broeker KA, Forst AL.   +7 more
europepmc   +1 more source

Methodological guidelines for P2X receptor assays and data interpretation. [PDF]

Cell Death Dis
Gorecki DC, Adinolfi E, Adriouch S, Coutinho-Silva R, Engel T, Gölöncsér F, Haag F, Illes P, Jacobson KA, Koch-Nolte F, Mansoor SE, Matute C, Melino G, Novak I, Pegoraro A, Pelegrin P, Piacentini M, Robson SC, Rumney RMH, Seman M, Sluyter R, Sperlagh B, Tang Y, Tarantini M, Ulrich H, Vouret-Craviari V, Ye Q, Yegutkin GG, Verkhratsky A.   +28 more
europepmc   +1 more source

Purinergic signaling in osteoarthritis: Mechanistic insights into pathogenesis and therapeutic targeting. [PDF]

Genes Dis
Li H, Wang T, Wang Z, Hou J, Li Z, Yan J.   +5 more
europepmc   +1 more source

P2 Receptors as Therapeutic Targets in Allergic Rhinitis: Insights From the Use of Natural Products and Preclinical Studies. [PDF]

J Immunol Res
Pereira TC, Rocha L, Faria RX.
europepmc   +1 more source

Proteasomal-dependent endothelial P2Y₆ receptor downregulation as an adaptive mechanism limiting monocyte adhesion during intestinal schistosomiasis. [PDF]

Purinergic Signal
Oliveira NF, Monteiro MMLV, Crepaldi LD, Coutinho-Silva R, Savio LEB, Silva CLM.   +5 more
europepmc   +1 more source